argenx to Report Third Quarter 2024 Financial Results and Business Update on October 31, 2024
24 Octubre 2024 - 12:00AM
October 24,
2024Amsterdam, the Netherlands – argenx
(Euronext & Nasdaq: ARGX), a global immunology company
committed to improving the lives of people suffering from severe
autoimmune diseases, today announced that it will host a conference
call and audio webcast on Thursday, October 31, 2024 at 1:30 PM CET
(8:30 AM ET) to discuss its third quarter 2024 financial results
and provide a business update.
A webcast of the live call may be accessed on the Investors
section of the argenx website at argenx.com/investors. A replay of
the webcast will be available on the argenx website for
approximately one year following the presentation.
Dial-in numbers:
Belgium 32 800
50
201France
33 800
943355Netherlands
31 20 795 1090United Kingdom 44 800 358 0970United
States 1 888 415
4250Japan
81 3 4578
9081Switzerland 41
43 210 11 32
Use the access code 3810049 to join the call. Please dial in 15
minutes prior to the live call.
About argenx
argenx is a global immunology company committed to improving the
lives of people suffering from severe autoimmune diseases.
Partnering with leading academic researchers through its Immunology
Innovation Program (IIP), argenx aims to translate immunology
breakthroughs into a world-class portfolio of novel antibody-based
medicines. argenx developed and is commercializing the first
approved neonatal Fc receptor (FcRn) blocker in the U.S., Japan,
Israel, the EU, the UK, Canada and China. The Company is evaluating
efgartigimod in multiple serious autoimmune diseases and advancing
several earlier stage experimental medicines within its therapeutic
franchises. For more information, visit www.argenx.com and follow
us on LinkedIn, X/Twitter, Instagram, Facebook, and YouTube.
For further information, please
contact:
Media:
Ben Petokbpetok@argenx.com
Investors:
Alexandra Roy (US)aroy@argenx.com
Lynn Elton (EU)lelton@argenx.com
argenx (NASDAQ:ARGX)
Gráfica de Acción Histórica
De Oct 2024 a Nov 2024
argenx (NASDAQ:ARGX)
Gráfica de Acción Histórica
De Nov 2023 a Nov 2024
